NCT00291213View on ClinicalTrials.gov

Levetiracetam Treatment of Tardive Dyskinesia

PHASE3CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

Not specified

Primary Completion Date

April 30, 2006

Conditions

Tardive Dyskinesia

Interventions

DRUG

levetiracetam

DRUG

placebo

Trial Locations (1)

06519

Connecticut Mental Health Center, New Haven

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

UCB Pharma

INDUSTRY

lead

Yale University

OTHER